BrightAccountsProduction v1.0.0 v1.0.0 2025-01-01 The company was not dormant during the period The company was trading for the entire period The principal activity of the company is that of distribution of scientific products. 8 June 2026 9 9 NI037486 2025-12-31 NI037486 2024-12-31 NI037486 2023-12-31 NI037486 2025-01-01 2025-12-31 NI037486 2024-01-01 2024-12-31 NI037486 uk-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 NI037486 uk-curr:PoundSterling 2025-01-01 2025-12-31 NI037486 uk-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 NI037486 uk-bus:FullAccounts 2025-01-01 2025-12-31 NI037486 uk-bus:Director1 2025-01-01 2025-12-31 NI037486 uk-bus:CompanySecretary1 2025-01-01 2025-12-31 NI037486 uk-bus:RegisteredOffice 2025-01-01 2025-12-31 NI037486 uk-bus:Agent1 2025-01-01 2025-12-31 NI037486 uk-bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 NI037486 uk-core:ShareCapital 2025-12-31 NI037486 uk-core:ShareCapital 2024-12-31 NI037486 uk-core:RetainedEarningsAccumulatedLosses 2025-12-31 NI037486 uk-core:RetainedEarningsAccumulatedLosses 2024-12-31 NI037486 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-12-31 NI037486 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-12-31 NI037486 uk-bus:FRS102 2025-01-01 2025-12-31 NI037486 uk-core:PlantMachinery 2025-01-01 2025-12-31 NI037486 uk-core:FurnitureFittingsToolsEquipment 2025-01-01 2025-12-31 NI037486 uk-core:MotorVehicles 2025-01-01 2025-12-31 NI037486 uk-core:CostValuation 2024-12-31 NI037486 uk-core:AdditionsToInvestments 2024-12-31 NI037486 uk-core:AdditionsToInvestments 2025-12-31 NI037486 uk-core:RevaluationsIncreaseDecreaseInInvestments 2025-12-31 NI037486 uk-core:CostValuation 2025-12-31 NI037486 uk-core:CurrentFinancialInstruments 2025-12-31 NI037486 uk-core:CurrentFinancialInstruments 2024-12-31 NI037486 uk-core:WithinOneYear 2025-12-31 NI037486 uk-core:WithinOneYear 2024-12-31 NI037486 uk-core:WithinOneYear 2025-12-31 NI037486 uk-core:WithinOneYear 2024-12-31 NI037486 uk-core:BadDebts 2024-12-31 NI037486 uk-core:BadDebts 2025-01-01 2025-12-31 NI037486 uk-core:AcceleratedTaxDepreciationDeferredTax 2025-12-31 NI037486 uk-core:TaxLossesCarry-forwardsDeferredTax 2025-12-31 NI037486 uk-core:OtherDeferredTax 2025-12-31 NI037486 uk-core:RevaluationPropertyPlantEquipmentDeferredTax 2025-12-31 NI037486 uk-core:BadDebts 2025-12-31 NI037486 2025-01-01 2025-12-31 xbrli:pure iso4217:GBP xbrli:shares

Company Registration Number: NI037486

Premier Scientific Limited

Director's Report and Unaudited Financial Statements

for the financial year ended 31 December 2025

Premier Scientific Limited

DIRECTOR AND OTHER INFORMATION

Director | Miss. Denise Rooney
Company Secretary | Mrs Fiona Guy
Company Registration Number | NI037486
Registered Office | 16 Mount Charles
| Belfast
| BT7 1NZ
Business Address | Unit 3 Westbank Drive
| Westbank Road
| Belfast
| Antrim
| BT3 9LA
| Northern Ireland
Accountants | Azets NI Limited
| Chartered Accountants
| 16 Mount Charles
| Belfast
| BT7 1NZ
Bankers | Santander Business Banking
| Bridle Road
| Bootle
| Liverpool
| L30 4GB
| AIB
| 35 University Road
| Belfast
| BT7 1ND
| Bank of Ireland
| 1 Donegall Square South
| BT1 5LR

Premier Scientific Limited

DIRECTOR'S REPORT

for the financial year ended 31 December 2025

The director presents her report and the unaudited financial statements for the financial year ended 31 December 2025.

Principal Activity

The principal activity of the company is that of distribution of scientific products.

Results and Dividends

The profit for the financial year after providing for depreciation and taxation amounted to £303,337 (2024 - £276,363).

Director

The director who served during the financial year is as follows:

Miss. Denise Rooney

There were no changes in shareholdings between 31 December 2025 and the date of signing the financial statements.

Charitable and political contributions

During the year the company made charitable donations of £1,024.

Statement of director's Responsibilities and Declaration on Unaudited Financial Statements

General responsibilities

The director is responsible for preparing the Director's Report and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" Section 1A (Small Entities). Under company law the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

- | select suitable accounting policies and apply them consistently;
- | make judgements and accounting estimates that are reasonable and prudent;
- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable her to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Director's declaration on unaudited financial statements

In relation to the financial statements comprising the Balance Sheet and the related notes:

The director approves these financial statements and confirms that she is responsible for them, including selecting the appropriate accounting policies, applying them consistently and making, on a reasonable and prudent basis, the judgements underlying them. They have been prepared on the going concern basis on the grounds that the company will continue in business.

The director confirms that she has made available to Azets NI Limited, (Chartered Accountants), all the company's accounting records and provided all the information, books and documents necessary for the compilation of the financial statements.

Special provisions relating to small companies

The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

On behalf of the board

___________________________

Miss. Denise Rooney

Director

8 June 2026

Premier Scientific Limited

CHARTERED ACCOUNTANTS REPORT

to the Director on the Compilation of the unaudited financial statements of Premier Scientific Limited

for the financial year ended 31 December 2025

In accordance with the engagement letter and in order to assist you to fulfil your duties under the Companies Act 2006, we have compiled for your approval the financial statements of the company for the financial year ended 31 December 2025 as set out on pages to which comprise the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given to us.

This report is made solely to the director of Premier Scientific Limited, in accordance with the terms of our engagement. Our work has been undertaken so that we might compile the financial statements that we have been engaged to compile, report to the company’s Director that we have done so, and state those matters that we have agreed to state to them in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and its director for our work or for this report.

We have carried out this engagement in accordance with guidance issued by Chartered Accountants Ireland and have complied with the relevant ethical guidance laid down by Chartered Accountants Ireland relating to members undertaking the compilation of financial statements.

You have acknowledged on the Balance Sheet for the year ended 31 December 2025 your duty to ensure that Premier Scientific Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Premier Scientific Limited. You consider that Premier Scientific Limited is exempt from the statutory audit requirement for the financial year.

We have not been instructed to carry out an audit or a review of the financial statements of Premier Scientific Limited. For this reason, we have not verified the adequacy, accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

__________________________________

AZETS NI LIMITED

Chartered Accountants

16 Mount Charles

Belfast

BT7 1NZ

8 June 2026

Premier Scientific Limited

Company Registration Number: NI037486

BALANCE SHEET

as at 31 December 2025

|  |  | 2025 |  | 2024
|  | Notes | £ |  | £
Fixed Assets

Tangible assets |  | 4 | 37,477 |  | 42,417
Investments |  | 5 | 1,104,713 |  | 88,266
|  |  | ───────── |  | ─────────
Fixed Assets |  |  | 1,142,190 |  | 130,683
|  |  | ───────── |  | ─────────
Current Assets

Stocks |  | 6 | 202,917 |  | 184,753
Debtors |  | 7 | 663,052 |  | 478,783
Cash and cash equivalents |  |  | 1,233,584 |  | 2,128,916
|  |  | ───────── |  | ─────────
|  |  | 2,099,553 |  | 2,792,452
|  |  | ───────── |  | ─────────
Creditors: amounts falling due within one year |  | 8 | (608,996) |  | (557,332)
|  |  | ───────── |  | ─────────
Net Current Assets |  |  | 1,490,557 |  | 2,235,120
|  |  | ───────── |  | ─────────
Total Assets less Current Liabilities |  |  | 2,632,747 |  | 2,365,803
Provisions for liabilities |  | 10 | (3,104) |  | (4,147)
|  |  | ───────── |  | ─────────
Net Assets |  |  | 2,629,643 |  | 2,361,656
|  |  | ═════════ |  | ═════════
Capital and Reserves

Called up share capital |  |  | 2 |  | 2
Retained earnings |  |  | 2,629,641 |  | 2,361,654
|  |  | ───────── |  | ─────────
Equity attributable to owners of the company |  |  | 2,629,643 |  | 2,361,656
|  |  | ═════════ |  | ═════════
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

The company has taken advantage of the exemption under section 444 not to file the Profit and Loss Account.

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Director and authorised for issue on 8 June 2026

________________________________ |  |  |  |  |
Miss. Denise Rooney |  |  |  |  |
Director |  |  |  |  |

Premier Scientific Limited

NOTES TO THE FINANCIAL STATEMENTS

for the financial year ended 31 December 2025

1. | General Information
| Premier Scientific Limited is a company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI037486. The registered office of the company is 16 Mount Charles, Belfast, BT7 1NZ. The nature of the company's operations and its principal activities are set out in the Director's Report. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

2. | Summary of Significant Accounting Policies
| The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
| Statement of compliance
| The financial statements of the company for the year ended 31 December 2025 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
| Basis of preparation
| The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
| Turnover
| Turnover represents the total invoice value, excluding value added tax, of sales made during the year. Revenue is recognised upon customer receipt.
| Tangible assets and depreciation
| Tangible assets are stated at cost, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost of tangible assets, less their estimated residual value, over their expected useful lives as follows:
|  | Plant and machinery | - | Fully Depreciated
|  | Fixtures, fittings and equipment | - | 12.5% Straight Line
|  | Motor vehicles | - | 25% Reducing Balance
| The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
| Investments
| Fixed asset investments are recognised initially at fair value which is normally the transaction price (but excludes any transaction costs, where the investment is subsequently measured at fair value through profit and loss). Subsequently, they are measured at fair value through profit or loss except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably which are recognised at cost less impairment until a reliable measure of fair value becomes available.
| Stocks
| Stocks are valued at the lower of cost and net realisable value. Stocks are determined on a first-in first-out basis. Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition. Full provision is made for obsolete and slow moving items. Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
| Trade and other debtors
| Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
| Borrowing costs
| Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
| Provisions
| Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
| Trade and other creditors
| Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
| Employee benefits
| Short-term employee benefits and contributions to defined contribution plans are recognised as an expense in the period in which they are incurred.
| Taxation and deferred taxation
| Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
| Foreign currencies
| Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Balance Sheet date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Profit and Loss Account.
| Pensions
| The pension costs charged in the financial statements represent the contribution payable by the company during the year.
| Ordinary share capital
| The ordinary share capital of the company is presented as equity.

3. | Employees
|  | 2025 | 2024
|  | Number | Number
| Employees | 9 | 9
|  | ═════════ | ═════════

4. | Tangible assets
|  | Plant and | Fixtures, | Motor | Total
|  | machinery | fittings and | vehicles |
|  |  | equipment |  |
|  | £ | £ | £ | £
| Cost
| At 1 January 2025 | 9,467 | 140,854 | 51,558 | 201,879
| Additions | - | 2,441 | 4,732 | 7,173
|  | ───────── | ───────── | ───────── | ─────────
| At 31 December 2025 | 9,467 | 143,295 | 56,290 | 209,052
|  | ───────── | ───────── | ───────── | ─────────
| Depreciation
| At 1 January 2025 | 9,467 | 127,675 | 22,320 | 159,462
| Charge for the financial year | - | 3,620 | 8,493 | 12,113
|  | ───────── | ───────── | ───────── | ─────────
| At 31 December 2025 | 9,467 | 131,295 | 30,813 | 171,575
|  | ───────── | ───────── | ───────── | ─────────
| Net book value
| At 31 December 2025 | - | 12,000 | 25,477 | 37,477
|  | ═════════ | ═════════ | ═════════ | ═════════
| At 31 December 2024 | - | 13,179 | 29,238 | 42,417
|  | ═════════ | ═════════ | ═════════ | ═════════

5. | Investments
|  | Other | Total
|  | investments |
| Investments | £ | £
| Cost or Valuation
| At 1 January 2025 | 88,266 | 88,266
| Additions | 1,000,100 | 1,000,100
| Revaluations | 16,347 | 16,347
|  | ───────── | ─────────
| At 31 December 2025 | 1,104,713 | 1,104,713
|  | ───────── | ─────────
| Net book value
| At 31 December 2025 | 1,104,713 | 1,104,713
|  | ═════════ | ═════════
| At 31 December 2024 | 88,266 | 88,266
|  | ═════════ | ═════════

6. | Stocks | 2025 | 2024
|  | £ | £
| Finished goods and goods for resale | 202,917 | 184,753
|  | ═════════ | ═════════

7. | Debtors | 2025 | 2024
|  | £ | £
| Trade debtors | 379,507 | 315,906
| Other debtors | 58,837 | 28,166
| Director's current account (Note 12) | 218,758 | 128,882
| Taxation (Note 9) | 1,029 | 1,029
| Prepayments and accrued income | 4,921 | 4,800
|  | ───────── | ─────────
|  | 663,052 | 478,783
|  | ═════════ | ═════════

8. | Creditors | 2025 | 2024
| Amounts falling due within one year | £ | £
| Bank overdrafts | 1,500 | 3,573
| Trade creditors | 459,993 | 432,333
| Taxation (Note 9) | 139,861 | 115,317
| Accruals | 7,642 | 6,109
|  | ───────── | ─────────
|  | 608,996 | 557,332
|  | ═════════ | ═════════

9. | Taxation | 2025 | 2024
|  | £ | £
| Debtors:
| PAYE / NI | 1,029 | 1,029
|  | ═════════ | ═════════
| Creditors:
| VAT | 12,215 | 18,650
| Corporation tax | 127,646 | 96,667
|  | ───────── | ─────────
|  | 139,861 | 115,317
|  | ═════════ | ═════════

10. | Provisions for liabilities
| The amounts provided for deferred taxation are analysed below:
|  | Capital | Total
|  | allowances |
|  | 2025 | 2024
|  | £ | £
| At financial year start | 4,147 | 4,116
| Charged to profit and loss | (1,043) | 31
|  | ───────── | ─────────
| At financial year end | 3,104 | 4,147
|  | ═════════ | ═════════

11. | Pension costs - defined contribution
| The company operates a money purchase pension scheme in respect of the director and staff. The scheme and its assets are held by independent managers. Pension costs amounted to £9,242 (2024 - £67,959).

12. | Director's advances, credits and guarantees
| During the year, the company made loans to the director amounting to £128,758.